← Back to Vaccine Database

ChimeriVax

Live attenuated vaccine · VDDBV0152

Target & Classification

DENVDengue virus
Live attenuated vaccine
Dengue; Dengue Disease
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials3

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT00730288 Phase 2Dengue
NCT00875524 Phase 2Dengue Disease
NCT00788151 Phase 2Dengue Disease